Midterm outcomes of sleeve gastrectomy in the elderly
- PMID: 30177427
- DOI: 10.1016/j.soard.2018.07.020
Midterm outcomes of sleeve gastrectomy in the elderly
Abstract
Background: The increase in life expectancy presents health systems with a growing challenge in the form of elderly obesity. Bariatric surgery has been shown to be a safe and effective treatment for obesity with reduction of excess weight and improvement in obesity-related co-morbidities. However, only recently have surgeons begun performing these operations on elderly patients on a larger scale, making data regarding mid- and long-term outcomes scarce. The objective of this study was to evaluate the safety and midterm efficacy of laparoscopic sleeve gastrectomy (LSG) in patients aged ≥60 years.
Methods: All patients aged ≥60 years who underwent LSG between 2008 and 2014 and achieved ≥24-month follow-up were retrospectively reviewed. Demographic characteristics and perioperative data were analyzed. Weight loss parameters and co-morbidity resolution rates were compared with preoperative data.
Results: In total 55 patients aged ≥60 years underwent LSG. Mean patient age was 63.9 ± 3.2 years (range, 60-75.2), and mean preoperative body mass index was 43 ± 6.0 kg/m2. Perioperative morbidity included 5 cases of hemorrhage necessitating operative exploration, 2 cases of reduced hemoglobin levels treated with blood transfusion, and 1 case of portal vein thrombosis managed with anticoagulation. There were no mortalities. Mean follow-up time was 48.6 (range, 25.6-94.5) months. Mean percentage of excess weight loss was 66.4 ± 19.7, 67.5 ±1 6.4, 61.4 ± 18.3, 66.7 ± 25.6, 50.7 ± 21.4 at 12, 24, 36, 37 to 60, and 61 to 96 months, respectively. Statistically significant improvement of type 2 diabetes, hypertension, and dyslipidemia were observed at the latest follow-up (P < .01).
Conclusion: LSG offers an effective treatment of obesity and its co-morbidities in patients aged ≥60 years, albeit with a high perioperative bleeding rate at our center; efficacy is maintained for at least 4.5 years.
Keywords: Bariatric surgery; Co-morbidities; Laparoscopy; Morbid obesity; Sleeve gastrectomy, Elderly patients.
Copyright © 2018 American Society for Bariatric Surgery. All rights reserved.
Comment in
-
Comment on: Midterm outcomes of sleeve gastrectomy in the elderly.Surg Obes Relat Dis. 2019 Feb;15(2):355. doi: 10.1016/j.soard.2018.10.007. Epub 2018 Oct 18. Surg Obes Relat Dis. 2019. PMID: 30467035 No abstract available.
-
Reply letter to the editor: Mid-term outcomes of sleeve gastrectomy in the elderly.Surg Obes Relat Dis. 2019 Feb;15(2):356. doi: 10.1016/j.soard.2018.12.016. Epub 2018 Dec 20. Surg Obes Relat Dis. 2019. PMID: 31010657 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical